Strieter; Robert M.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Strieter; Robert M..The latest application filed is for "methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals".

Company Profile

0.10.9

Strieter; Robert M. - Sherman Oaks CA
Strieter; Robert M. - Charlottesville VA
Strieter; Robert M. - Ann Arbor MI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods Of Using Secondary Lymphoid Organ Chemokine To Modulate Physiological Processes In Mammals App 20160058837 - Dubinett; Steven M. ; et al.	2016-03-03
Compositions And Methods For Using And Identifying Antimicrobial Agents App 20120321687 - Hughes; Molly A. ; et al.	2012-12-20
Methods for treating and diagnosing fibrotic and fibroproliferative diseases Grant 8,216,796 - Mehrad , et al. July 10, 2	2012-07-10
Methods For Treating And Diagnosing Fibrotic And Fibroproliferative Diseases App 20120094305 - Mehrad; Borna ; et al.	2012-04-19
Methods for treating and diagnosing fibrotic and fibroproliferative diseases Grant 8,114,608 - Mehrad , et al. February 14, 2	2012-02-14
Methods for Treating and Diagnosing Fibrotic and Fibroproliferative Diseases App 20100074887 - Mehrad; Borna ; et al.	2010-03-25
Treatment of idiopathic pulmonary fibrosis using IP-10 Grant 7,265,083 - Strieter , et al. September 4, 2	2007-09-04
Methods of treating idiopathic pulmonary fibrosis App 20070092488 - Strieter; Robert M. ; et al.	2007-04-26
Methods for inhibition of HIV replication using a small molecule inhibitor Grant 7,052,676 - Markovitz , et al. May 30, 2	2006-05-30
Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals App 20040175355 - Dubinett, Steven M. ; et al.	2004-09-09
Treatment of liver disease and injury with CXC chemokines Grant 6,719,969 - Hogaboam , et al. April 13, 2	2004-04-13
Methods of using secondary lymphoid organ chemokine to modulate physiological processes in mammals App 20030175801 - Dubinett, Steven M. ; et al.	2003-09-18
Treatment of idiopathic pulmonary fibrosis using IP-10 App 20030031645 - Strieter, Robert M. ; et al.	2003-02-13
Novel methods for inhibition of HIV replication App 20030026802 - Markovitz, David M. ; et al.	2003-02-06
Method for treating asthma using SCF antibody Grant 5,911,988 - Brownell , et al. June 15, 1	1999-06-15
CXC chemokines as regulators of angiogenesis Grant 5,871,723 - Strieter , et al. February 16, 1	1999-02-16
Radiolabeled neutrophil activating peptides for imaging Grant 5,605,671 - Lyle , et al. February 25, 1	1997-02-25
Therapeutic treatment for inhibiting vascular restenosis Grant 5,571,713 - Lyle , et al. November 5, 1	1996-11-05
Labelled monocyte chemoattractant protein material and medical uses thereof Grant 5,413,778 - Kunkel , et al. May 9, 1	1995-05-09

Company Registrations

NCAGE Code	49W35	STRIETER ROBERT M
NCAGE Code	4P7F8	STRIETER ROBERT M
CAGE Code	49W35	STRIETER, ROBERT M
CAGE Code	4P7F8	STRIETER, ROBERT M
DUNS	791548410	STRIETER, ROBERT M

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.